Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

418P - Lessons learnt from treatment of foot sarcomas: Analysis from dedicated sarcoma clinic in North India

Date

23 Nov 2019

Session

Poster display session

Topics

Tumour Site

Sarcoma

Presenters

Satyajit Pawar

Citation

Annals of Oncology (2019) 30 (suppl_9): ix135-ix139. 10.1093/annonc/mdz433

Authors

S.J. Pawar1, S. Rastogi1, E. Dhamija2, A. Barwad3, V. Kumar4, R. Pandey5, S. Shishak5, K. Kalra1, A. Aggarwal6, A. Garg1, A.R. Mridha3, J. Chaubey7, S.A. Khan4

Author affiliations

  • 1 Medical Oncology Department, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 2 Radiology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 3 Department Of Pathology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 4 Department Of Orthopedics, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 5 Department Of Radiation Oncology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 6 Department Of Radiation Oncology, National Cancer Institute, AIIMS Jhajjar, 124105 - Badsa/IN
  • 7 Department Of Medicine, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 418P

Background

There is sparse data available on foot sarcomas treated on contemporary protocols.

Methods

This retrospective analysis involved 27 cases of foot sarcomas managed with multi-modality treatment under Sarcoma Clinic, at tertiary care hospital between January 2014 to May 2019. Baseline demographics, radiographic tumour characteristics, histological diagnosis, type of treatment received and oncological outcomes were noted for all cases. Statistical analysis was done by STATA version 13.0. Survival curves were analyzed by Kaplan Meir test and univariate analysis was done by Log Rank test.

Results

Median age was 26 years (range: 20 – 46 years). Median duration of symptoms were 11 months (Range: 5 – 24 months). Radiologically mean largest diameter of tumour was 6.5 cm (CI: 1.1 – 12 cm). Seven tumours (26%) arose from bone and 20 form soft tissue (74%). In tumours arising from bone, metatarsal was most commonly site of involvement (3 out of 7). Most common histology was synovial sarcoma (44%) f/b Ewing’s sarcoma (26%) f/b others (RMS, DFSP, MPNST, angiosarcoma). Ten patients (37%) had metastatic disease at presentation, lung being most common site (80%). Histological discordance with review diagnosis was seen in 50 % cases. Amputation was needed in 10 cases (37%) (palliative - 5, curative - 5) while limb salvage surgery was done in 10 (all curative). Adjuvant radiation was given in 7 out of 10 cases (70%). At last follow up 16 out of 27 patients (60%) were alive without disease, 4 (11%) with disease while 8 (29%) have died. With median follow-up of 43 months (Range 8 - 63 months) median PFS was 22 months. Median PFS in non-metastatic group was 48 months, while in metastatic group it was 8 months. On univariate analysis, median OS was significantly different between metastatic vs non-metastatic group (HR 10.93, p = 0.03).

Conclusions

Foot sarcomas happen in young adults irrespective of pathology with synovial sarcoma and Ewing’s sarcoma being most common histologies. Amputation rates are quite high even considering small size, owing to anatomy of the region as noted in previous studies. The treatment required for non metastatic disease is multimodality including use of radiation. If treated in multidisciplinary clinic outcomes can certainly be improved.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Sameer Rastogi.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.